Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China's first artificial intelligence-assisted Category 1 new drug to reach this ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Oluwaseun Ajayi is a globally trained real estate economist and climate-risk scholar recognised for advancing how ...

Mutuum Finance gains momentum in presale phase 7 as analysts compare its utility-driven growth to early Binance Coin.

As the crypto market moves deeper into a mature cycle, investor focus is starting to change. Large caps still dominat ...

Comet C/2025 R3 (PanSTARRS) is already being talked about as the sky spectacle to watch in 2026, with some wondering if it might rise to the rare status of a “great comet.” The object is on track to ...

This is one in a series looking at what Lake County communities, agencies, and school districts experienced in 2025 and what ...

We are now in one of those periods, which obliges the United States to rethink its role in the world, just as it was forced to do by the cataclysmic changes that followed the end of the Second World ...

Optimism for AI-powered drug discovery is rising as industry giants, startups, and even Sam Altman step up investments ...

Hello, ambitious Capricorn! You're known for your discipline, practicality, and determination to climb the ladder of success.

T'puram: Submission of revised detailed project report (DPR) for the ambitious Thiruvananthapuram Metro Rail project hit a ...